For this very first event, a series of events and initiatives driven by the members of France BioLead in collaboration with the entire ecosystem, deployed across all territories will take place.

Eurobiomed is pleased to invite you to the event to be held in Occitanie on Evotec’s Curie Campus, from 10am to 12pm (5 July).

Evotec, GTP Bioways and Flash BioSolutions invite you to learn more about biomedicines and the biomanufacturing value chain, as well as the jobs biomanufacturing value chain, as well as the jobs and opportunities in the industry.
This event is primarily aimed at future talent in the field, but is open to anyone interested in open to anyone with an interest in the subject, who would like to to develop their understanding of the sector.

On the menu:
·       Come and meet our industry and its players
·       Discover a wide range of career and training opportunities
·       Speed-dating to discover bioproduction job profiles
·       Quiz on bioproduction

Adoptive cell therapy, particularly CAR T-cell therapy, has marked a revolutionary milestone in the treatment of hematological malignancies and is now making strides in the realm of auto-immune diseases. However, for solid tumors, there remains a substantial path ahead.

This congress will delve into the critical aspects of optimizing adoptive cell therapy;
– The host conditions for greater efficacy of adoptive cell therapy.
– Focus on T-cell engineering, novel targets for CAR T-cell therapy.

Date : 30-31 May

Location : the Cordeliers Research Centre.

The meeting is designed to provide networking between clinicians, scientists from academic and industrial parterns in the field of cell therapies.

For those keen on diving deeper into biomanufacturing and gene delivery, we invite you to schedule a meeting with :

• Christine Duthoit, Chief Innovation Officer
• Alexandra Iché, Gene Engineering Project Manager
• Antoinette Crooke, Business Developper
• Patricia Canivenq, R&D Product Manager

Don’t miss this opportunity to be part of the dialogue driving forward the future of advanced therapies.

To register at this meeting : https://www.eventcreate.com/e/improving-adoptive-cell-therapy

Anne DEFLISQUE, based in Toulouse, Occitanie, France, brings a wealth of experience to her new role, having previously served as the Sales and Marketing Director at Vaiomer. Her professional journey includes notable positions at MilleGen, and in bio-process divisions of GE Healthcare and Pharmacia Biotech (Cytiva). With a diverse background spanning various facets of the industry, Anne holds an Engineering degree in Biotechnologies (PBA) from UTC (Université de Technologie de Compiègne – France).

Anne’s extensive skill set encompasses Development, International Business, Technology, Key Account Management, Open Innovation, and more, positioning her as a valuable asset to Flash BioSolutions. In her new capacity, she will lead the company’s commercialization strategy, with a focus on identifying new opportunities for growth and nurturing relationships with clients and partners. Anne’s leadership and innovative mindset will play a pivotal role in consolidating Flash BioSolutions’ position as the leading CDMO in DNA and RNA gene delivery.

Anne DEFLISQUE’s appointment aligns strategically with Flash BioSolutions’ expansion efforts, as the company remains dedicated to delivering cutting-edge biotechnology solutions to its global clientele.

“We are delighted to welcome Anne DEFLISQUE to the leadership team at Flash BioSolutions. Her wealth of experience and expertise will be instrumental in driving our strategic objectives forward,” commented Jérôme Bédier, CEO of Flash BioSolutions. “Her appointment underscores our unwavering commitment to excellence and our determination to innovate and thrive in an ever-evolving business landscape.”

Anne DEFLISQUE expressed “I am thrilled to join Flash BioSolutions at such an exciting time in the company’s growth trajectory. I look forward to leveraging my experience and skills to drive forward our commercialization strategy and foster impactful collaborations with our clients and partners. I am deeply committed to advancing Flash BioSolutions’ mission of delivering innovative biotechnology solutions to address the evolving needs of the gene and cell therapy field. Together, we will continue to push the boundaries of excellence and drive positive outcomes for patients worldwide.”